Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
The Analysis of Binary Data.
1971 • 2,339 citations
The randomization and stratification of patients to clinical trials
1974 • 595 citations
Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule
1974 • 393 citations
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.
1987 • 284 citations
Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas
1987 • 244 citations
Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.
1989 • 242 citations
A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma
1982 • 170 citations
Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
1987 • 95 citations
Metastatic sarcomas: Chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristine
1981 • 20 citations
Chemotherapy of patients with advanced soft tissue sarcoma with use of DVA (vindesine sulfate), adriamycin and cyclophosphamide (DAC)
1983 • 15 citations
Recommendations for clinical protocol development and definition of therapeutic response for soft-tissue sarcomas
1980 • 7 citations
Effect of desacetyl vinblastine amide (DVA) against human sarcomas heterotransplanted in nude mice.
1980 • 6 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database